ReviewFrontiers in digital health2026
Technological innovation in healthcare: challenges, opportunities and impact on sustainability.
Review in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peripheral blood biomarkers in PD-1/PD-L1 immunotherapy: distinguishing predictive from prognostic biomarkers.Frontiers in immunology · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare technologies are increasingly reshaping how diseases are detected, monitored, treated, and managed across healthcare systems. Advances in artificial intelligence (AI), digital health, remote monitoring, advanced medical devices, and data-driven clinical infrastructures are creating important opportunities to improve prevention, diagnostic accuracy, personalisation of care, workflow efficiency, and long-term healthcare sustainability within the framework of predictive, preventive, personalized, and participatory medicine (4P Medicine). However, despite growing technological sophistication and investment, many innovations fail to achieve scalable and sustainable implementation in real-world clinical environments. This narrative review critically examines the systemic factors that condition the successful translation of healthcare technologies into routine clinical practice, with particular emphasis on the European and Spanish contexts. Rather than focusing exclusively on technological performance, the review analyses the broader regulatory, organisational, financial, ethical, and governance challenges that shape implementation. Key areas discussed include technology transfer, regulatory frameworks, health data governance, and the organisational challenges associated with implementing AI-driven healthcare technologies. The central argument of this review is that the real-world impact of healthcare innovation depends less on technological capability itself than on the capacity of healthcare systems to support validation, regulation, implementation, workforce adaptation, interoperability, and long-term governance. Consequently, the principal challenge for contemporary healthcare systems is no longer simply how to develop new technologies, but how to integrate them safely, equitably, and sustainably into routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.